Company Profile: OpenDNA Limited (ASX: OPN) happens to be an artificial intelligence company. The principal activities revolve around deployment as well as sale with regards to OpenDNA’s patent-pending artificial intelligence system. As per the annual report of the company, the company has operations in the Singapore, Australia as well as South Africa. The company’s stock is being traded on Australian Securities Exchange or ASX under the symbol “OPN.”
Start discussion with value Investors for ASX Stock Market Investment and Opinion.
Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s
Those phrases have become increasingly common as marijuana legalization spreads.
Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.
Click here for your FREE Report